mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.02 |
mRNA |
BRD-K92856060 |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.02 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.02 |
mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.02 |
mRNA |
Bortezomib |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
0.02 |
mRNA |
CIL70 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.03 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.03 |
mRNA |
semagacestat |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.03 |
mRNA |
Vorinostat |
gCSI |
pan-cancer |
AAC |
-0.14 |
0.03 |
mRNA |
GSK269962A |
GDSC1000 |
pan-cancer |
AAC |
-0.077 |
0.03 |